Delayed Complete Clearance of Recalcitrant Warts Due to Intralesional Measles, Mumps, and Rubella: Case Report and Review

被引:0
|
作者
Varghese, Angel [1 ]
George, Nithin M. [2 ]
Wadhwa, Shivani [1 ]
机构
[1] Fakeeh Univ Hosp, Dept Dermatol, Dubai, U Arab Emirates
[2] Sichuan Univ, West China Sch Med, Dept Dermatol, Chengdu, Sichuan, Peoples R China
关键词
flat warts; common warts; human papillomavirus; periungual warts; recalcitrant warts; mmr for warts; immunotherapy; palmoplantar warts; MMR VACCINE; IMMUNOTHERAPY; INJECTION; EFFICACY; SAFETY;
D O I
10.7759/cureus.67225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Warts are a prevalent skin condition that can affect people of any age. They are caused by the human papillomavirus (HPV), a double-stranded DNA virus that can cause benign and malignant lesions and remains latent in the host cells, leading to recurrences. Although warts are benign and spontaneous clearance has been reported over the years, they often cause disfigurement, tend to koebnerize, and can be transmitted to others, making adequate and timely treatment important. Several conventional treatments are available, but none works consistently for all patients. Incomplete responses or recurrences are often bothersome to both patients and dermatologists. Moreover, these treatments are often painful, timeconsuming, and can cause significant scarring. Immunotherapy, as an alternative, has found a significant place in the treatment of warts because of its non-destructive action, ease of use, and promising results. This paper will discuss a healthy 36-year-old Bosnian male with chronic palmoplantar and periungual warts. Despite undergoing multiple destructive and topical treatments, including electrocautery, cryotherapy, carbon dioxide laser, salicylic acid, glycolic acid, 5-fluorouracil, and imiquimod, he could not achieve significant improvement in his skin condition. Subsequent treatment with the intralesional measles, mumps, rubella (MMR) vaccine also showed little improvement during treatment. However, three months without further treatment, the patient reported complete resolution of the warts. Follow-up confirmed the clearance with no recurrence and minor post-inflammatory hypopigmentation. Our patient's delayed response to the MMR vaccine aligns with findings from other studies indicating that the body's immune response may take time to manifest fully.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach
    Nofal, Ahmad
    Nofal, Eman
    Yosef, Ayman
    Nofal, Hager
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (06) : 667 - 671
  • [2] The use of intralesional measles-mumps-rubella vaccine in the treatment of recalcitrant viral warts
    Leung, An Jian
    Yang, Sam Shiyao
    Zhang, Agnes Hui Mei
    Tan, Kim Lian
    Lim, Brenda Bee Khim
    Chua, Sze Hon
    Yong, Angeline Arming
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB294 - AB294
  • [3] Intralesional immunotherapy of warts with mumps, measles and rubella vaccine
    Choi, Hoon
    Kim, Hae Ryun
    Na, Chan Ho
    Kim, Min Sung
    Shin, Bong Seok
    Choi, Kyu Chul
    JOURNAL OF DERMATOLOGY, 2012, 39 : 63 - 64
  • [4] Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts
    Ulschmid, Caden M.
    Patel, Jay
    Pan, Amy Y. Y.
    Liegl, Melodee
    Holland, Kristen E.
    PEDIATRIC DERMATOLOGY, 2023, 40 (06) : 1057 - 1059
  • [5] Intralesional mumps, measles and rubella vaccine in the treatment of cutaneous warts
    Saini, Poonam
    Mittal, Asit
    Gupta, Lalit K.
    Khare, Ashok K.
    Mehta, Sharad
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (03): : 343 - U240
  • [6] Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine
    Nofal, A.
    Nofal, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (10) : 1166 - 1170
  • [7] The Efficacy of Intralesional Measles, Mumps, Rubella (MMR) Antigen in Treatment of Common Warts
    Naseem, Riffat
    Aamir, Safoora
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2013, 7 (04): : 1130 - 1133
  • [8] Measles, mumps, and rubella vaccine in genital warts: A case report of two patients
    Meena, Dilip
    Sharma, Shilpi
    Chauhan, Payal
    INDIAN JOURNAL OF SEXUALLY TRANSMITTED DISEASES AND AIDS, 2018, 39 (02) : 133 - 135
  • [9] Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional Candida Antigen in the Treatment of Common and Plantar Warts
    Nofal, Ahmad
    El-arab, Reda Ezz
    Nasr, Mohamed
    Alakad, Rania
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2021, 25 (04) : 377 - 383
  • [10] Intralesional Measles, Mumps, and Rubella Vaccine versus Cryotherapy in Treatment of Warts: A Prospective Study
    Rajegowda, Harish M.
    Kalegowda, Deepadarshan
    Madegowda, Shashi K. B.
    Palanayak, Jayashree K.
    JOURNAL OF DERMATOLOGY & DERMATOLOGIC SURGERY-JDDS, 2020, 24 (02): : 110 - 115